The density and spatial tissue distribution of CD8+ and CD163+ immune cells predict response and outcome in melanoma patients receiving MAPK inhibitorsMario Mandalà, Marco Tucci, Marcella Occelli et al.|Journal for ImmunoTherapy of Cancer|2019Cited by 68
miR-146a-5p impairs melanoma resistance to kinase inhibitors by targeting COX2 and regulating NFkB-mediated inflammatory mediatorsElisabetta Vergani, Viviana Vallacchi, Matteo Dugo et al.|Cell Communication and Signaling|2020Cited by 36
Genetic Layout of Melanoma Lesions Is Associated with BRAF/MEK-Targeted Therapy Resistance and Transcriptional ProfilesElisabetta Vergani, Monica Rodolfo, Adele Busico et al.|Journal of Investigative Dermatology|2022Cited by 14
Liquid Biopsy and Radiological Response Predict Outcomes Following Discontinuation of Targeted Therapy in Patients with <i>BRAF</i> Mutated MelanomaLorenza Di Guardo, Michele Del Vecchio, Giovanni Randon et al.|The Oncologist|2021Cited by 10
Combined Therapy with Dabrafenib and Trametinib in <i>BRAF</i>-Mutated Metastatic Melanoma in a Real-Life Setting: The INT Milan ExperienceStefano Cavalieri, Michele Del Vecchio, Lorenza Di Guardo et al.|Tumori Journal|2016Cited by 8